Michael A. Panzara, Franchise Lead, Neurology at Wave Life Sciences Ltd. (WVE), sold 3,674 shares at $36.84 ($135K) on 2019-02-19, disclosed to the SEC on 2019-02-21.
Open-market sale of $135k WVE by Franchise Lead, Neurology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.84 | 1,837 | $68K | 50.0% |
| 2 | $36.84 | 1,837 | $68K | 50.0% |
| Total | $36.84 avg | 3,674 | $135K | 100% |
| Filing → |
| WVE | SELL | 2021-02-18 | $31K | — | Filing → |
| WVE | SELL | 2020-02-20 | $23K | — | Filing → |
| WVE | SELL | 2019-07-09 | $153K | — | Filing → |